Fresenius Medical Care beats profit and sales forecasts for the September quarter

what happened

Fresenius Medical Care has published its figures for the three months ended September 30. According to Earnings Summary, which relies on LSEG data, adjusted profit came to 56 cents per share, up from 55 cents a year earlier. Two analysts had penciled in 53 cents, while the wider Street range ran from 51 to 55 cents.

Sales grew 1.1% to €4.94 billion, whereas analysts had projected €4.86 billion. Statutory earnings per share were 31 cents. Over the quarter the stock gained 1.0%, yet it is down 5.1% year to date.

Analyst earnings estimates rose roughly 0.8% over the past three months, with no downward revisions in the last 30 days. The average rating on the shares is 'sell', with two holds and four sell or strong sell calls, while the healthcare facilities and services peer group carries a 'buy' consensus. The median 12-month price target is $22.08, about 2.4% below the last close of $22.61.

why it matters

For investors the picture is mildly positive: the company topped consensus on both profit and revenue, though analyst ratings remain cautious and the shares are still negative so far this year.

market impact

Fresenius Medical Care shares: profit and sales above forecasts support the stock

• ▲Fresenius Medical Care shares pressure up — profit and sales came in above analyst forecasts

tags

instruments